Viridian Therapeutics, Inc.DE - Common Stock (VRDN)
CUSIP: 92790C104
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 95,489,675
- Total 13F shares
- 5,057,213
- Share change
- +4,828,213
- Total reported value
- $84,503,000
- Price per share
- $16.71
- Number of holders
- 28
- Value change
- +$80,676,000
- Number of buys
- 26
Quarterly Holders Quick Answers
What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92790C104:
Top shareholders of VRDN - Viridian Therapeutics, Inc.DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Advisors, Inc. |
13F
|
Company |
0.22%
|
209,505
|
$3,446,000 | — | 31 Dec 2020 | |
| VR Adviser, LLC |
13F
|
Company |
0.02%
|
19,495
|
$321,000 | — | 31 Dec 2020 |
Institutional Holders of Viridian Therapeutics, Inc.DE - Common Stock (VRDN) as of Q1 2021
As of 31 Mar 2021,
Viridian Therapeutics, Inc.DE - Common Stock (VRDN) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,057,213 shares.
The largest 10 holders included
Ally Bridge Group (NY) LLC, WELLINGTON MANAGEMENT GROUP LLP, Logos Global Management LP, BVF INC/IL, Cormorant Asset Management, LP, Point72 Asset Management, L.P., RA CAPITAL MANAGEMENT, L.P., Ghost Tree Capital, LLC, Atlas Venture Advisors, Inc., and D. E. Shaw & Co., Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
2
Q1 2021 holders
28
Holder diff
26
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.